Revance Therapeutics, Crown Labs Again Extend Tender Offer Deadline
Mizuho Securities Maintains Revance Therapeutics(RVNC.US) With Hold Rating
Revance Therapeutics (RVNC) Gets a Hold From Mizuho Securities
Analysts Have Conflicting Sentiments on These Healthcare Companies: Trevi Therapeutics (TRVI), Conmed (CNMD) and Revance Therapeutics (RVNC)
Express News | Revance Therapeutics: Extends Tender Offer Commencement Date to Oct 18
Down -17.96% in 4 Weeks, Here's Why Revance Therapeutics (RVNC) Looks Ripe for a Turnaround